Fudan University Shanghai Cancer Hospital

Shanghai 200032

1 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Advanced Solid Tumors, Biliary Tract Cancer, Cholangiocarcinoma, Diffuse Large B-Cell Lymphoma, Gallbladder Cancer

Studies at this site

• Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors — Recruiting now
• Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ — Completed
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC — Stopped early